Document is current
Any future updates will be listed below
-
Authors
Gülke, Eileen https://orcid.org/0000-0003-1654-4443
Juárez Paz, León https://orcid.org/0000-0002-1621-1318
Scholtes, Heleen
Gerloff, Christian
Kühn, Andrea A. https://orcid.org/0000-0002-4134-9060
Pötter-Nerger, Monika https://orcid.org/0000-0001-7680-2147
-
Funding
Funding for this research was provided by:
Boston Scientific Corporation
- License Information
-
More Information
Article History
Received: 25 April 2022
Accepted: 14 September 2022
First Online: 29 October 2022
Competing interests
: The authors declare no competing non-financial interests but the following competing financial interests: E.G.: reports honoraria (Abbvie, Abbott, Medtronic, Bial, Grifols, Zambon/Weser GmbH, Kreiskrankenhaus Gummersbach), contract (Thieme). L.J.P.: full time employee of Boston Scientific. H.S.: full time employee of Boston Scientific. C.G.: reports honoraria from Bayer Healthcare, Boehringer Ingelheim, Acticor Biotech, Sanofi Aventis Amgene, and Prediction Bioscience. A.A.K.: declares that she is on the advisory board of Boston Scientific and Medtronic and has received honoraria from Boston Scientific, Medtronic, Abbott, Teva und Ipsen. M.P.-N.: received lecture fees from Abbott, Abbvie, Boston Scientific and Licher, and served as consultant for Medtronic, Boston Scientific, Abbott, Zambon, and Abbvie.
